Log in
Enquire now
Selecta Biosciences

Selecta Biosciences

Selecta Bioscience is a clinical-stage biopharmaceutical company founded in 2008 by Omid Farokhzad.

OverviewStructured DataIssuesContributors

Contents

selectabio.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Nanotechnology
Nanotechnology
0
Vaccine
Vaccine
‌
Nanomedicine
Autoimmune disease
Autoimmune disease
Biomedical engineering
Biomedical engineering
...
Location
Watertown, Massachusetts
Watertown, Massachusetts
0
United States
United States
B2X
B2C
B2C
B2B
B2B
0
CEO
Carsten Brunn
Carsten Brunn
Founder
Robert S. Langer
Robert S. Langer
Ulrich von Andrian
Ulrich von Andrian
Omid Farokhzad
Omid Farokhzad
AngelList URL
angel.co/selecta-biosciences
Pitchbook URL
pitchbook.com/profiles.../51604-12
Legal Name
Selecta Biosciences, Inc.0
Legal classification
Corporation
Corporation
Number of Employees (Ranges)
51 – 200
Email Address
info@selectabio.com0
Phone Number
+161792314000
Number of Employees
580
Full Address
65 Grove Street Watertown, MA 02472 United States0
CIK Number
1,453,6870
Place of Incorporation
Delaware
Delaware
0
Investors
I2BF Global Ventures
I2BF Global Ventures
Skolkovo Foundation
Skolkovo Foundation
OrbiMed
OrbiMed
Polaris Partners
Polaris Partners
‌
Timothy A. Springer
Rusnano
Rusnano
RUSNANO Capital
RUSNANO Capital
DUNS Number
8096039830
Founded Date
2023
0
Total Funding Amount (USD)
231,550,000
Latest Funding Round Date
September 2015
Business Model
Commerce
Stock Symbol
SELB0
Exchange
Nasdaq
Nasdaq
0
Glassdoor ID
592009
Board of Directors
‌
Patrick Zenner
0
‌
Carrie S. Cox
0
‌
Goran A. Ando
0
‌
Timothy A. Springer
0
Aymeric Sallin
Aymeric Sallin
0
Carsten Brunn
Carsten Brunn
0
‌
Scott D. Myers
0
‌
Nishan De Silva
0
...
CFO
‌
Kevin Tan
0
Latest Funding Type
Series E
Series E
NAICS Code
325,4120
CAGE Code
50Q970
COO
‌
Lloyd Johnston
0
Wellfound ID
selecta-biosciences
Country
United States
United States

Other attributes

Company Operating Status
Active
SIC Code
2,8340
Ticker Symbol
SELB0
Wikidata ID
Q30288672

Selecta Bioscience develops nanoparticle immunomodulatory drugs for treating and preventing human diseases. It develops tolerogenic therapies that induce tolerance to highly immunogenic proteins for the mitigation of unwanted immune responses through the company’s clinically validated ImmTOR™ platform. It is headquartered in Watertown, MA.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Selecta Biosciences

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.